ArticleThrombosis journal2025

Predictive thresholds of peak and trough anti-Xa levels for bleeding risk in rivaroxaban-treated nonvalvular atrial fibrillation.

Mouhammad Rida Almouwannes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.